vs
爱齐科技（ALGN）与RedHill Biopharma Ltd.（RDHL）财务数据对比。点击上方公司名可切换其他公司
爱齐科技的季度营收约是RedHill Biopharma Ltd.的57.1倍（$1.0B vs $18.3M）。爱齐科技净利率更高（13.0% vs -63.8%，领先76.8%）。爱齐科技同比增速更快（5.3% vs -14.7%）
爱齐科技是一家全球知名医疗设备企业，主营设计、生产及销售隐适美透明矫治器、iTero口内扫描仪及配套服务，客户覆盖正畸医师、全科牙医，面向修复、美容牙科领域，业务分为透明矫治器、扫描仪及服务两大板块，可满足青少年等不同群体的正畸需求
RedHill生物制药是一家专科生物制药企业，专注于胃肠道疾病、炎症性疾病及感染性疾病创新疗法的研发与商业化，核心市场覆盖北美及欧洲，针对未被满足的临床需求开发处方治疗药物，与全球医疗伙伴合作提升产品可及性。
ALGN vs RDHL — 直观对比
营收规模更大
ALGN
是对方的57.1倍
$18.3M
营收增速更快
ALGN
高出19.9%
-14.7%
净利率更高
ALGN
高出76.8%
-63.8%
损益表 — Q4 2025 vs Q2 2022
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $18.3M |
| 净利润 | $135.8M | $-11.7M |
| 毛利率 | 65.3% | 51.0% |
| 营业利润率 | 14.8% | -49.9% |
| 净利率 | 13.0% | -63.8% |
| 营收同比 | 5.3% | -14.7% |
| 净利润同比 | 30.8% | 59.8% |
| 每股收益（稀释后） | $1.88 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALGNRDHL
| Q4 25 | $1.0B | — | ||
| Q3 25 | $995.7M | — | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $979.3M | — | ||
| Q4 24 | $995.2M | — | ||
| Q3 24 | $977.9M | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $997.4M | — |
净利润ALGNRDHL
| Q4 25 | $135.8M | — | ||
| Q3 25 | $56.8M | — | ||
| Q2 25 | $124.6M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $103.8M | — | ||
| Q3 24 | $116.0M | — | ||
| Q2 24 | $96.6M | — | ||
| Q1 24 | $105.0M | — |
毛利率ALGNRDHL
| Q4 25 | 65.3% | — | ||
| Q3 25 | 64.2% | — | ||
| Q2 25 | 69.9% | — | ||
| Q1 25 | 69.5% | — | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 69.7% | — | ||
| Q2 24 | 70.3% | — | ||
| Q1 24 | 70.0% | — |
营业利润率ALGNRDHL
| Q4 25 | 14.8% | — | ||
| Q3 25 | 9.7% | — | ||
| Q2 25 | 16.1% | — | ||
| Q1 25 | 13.4% | — | ||
| Q4 24 | 14.5% | — | ||
| Q3 24 | 16.6% | — | ||
| Q2 24 | 14.3% | — | ||
| Q1 24 | 15.5% | — |
净利率ALGNRDHL
| Q4 25 | 13.0% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 12.3% | — | ||
| Q1 25 | 9.5% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 11.9% | — | ||
| Q2 24 | 9.4% | — | ||
| Q1 24 | 10.5% | — |
每股收益（稀释后）ALGNRDHL
| Q4 25 | $1.88 | — | ||
| Q3 25 | $0.78 | — | ||
| Q2 25 | $1.72 | — | ||
| Q1 25 | $1.27 | — | ||
| Q4 24 | $1.40 | — | ||
| Q3 24 | $1.55 | — | ||
| Q2 24 | $1.28 | — | ||
| Q1 24 | $1.39 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $27.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.0B | $-11.9M |
| 总资产 | $6.2B | $168.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALGNRDHL
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $901.2M | — | ||
| Q1 25 | $873.0M | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $761.4M | — | ||
| Q1 24 | $865.8M | — |
股东权益ALGNRDHL
| Q4 25 | $4.0B | — | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $3.9B | — | ||
| Q1 25 | $3.8B | — | ||
| Q4 24 | $3.9B | — | ||
| Q3 24 | $3.9B | — | ||
| Q2 24 | $3.8B | — | ||
| Q1 24 | $3.8B | — |
总资产ALGNRDHL
| Q4 25 | $6.2B | — | ||
| Q3 25 | $6.2B | — | ||
| Q2 25 | $6.2B | — | ||
| Q1 25 | $6.1B | — | ||
| Q4 24 | $6.2B | — | ||
| Q3 24 | $6.4B | — | ||
| Q2 24 | $6.2B | — | ||
| Q1 24 | $6.2B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $223.2M | $-16.6M |
| 自由现金流经营现金流 - 资本支出 | $187.3M | — |
| 自由现金流率自由现金流/营收 | 17.9% | — |
| 资本支出强度资本支出/营收 | 3.4% | — |
| 现金转化率经营现金流/净利润 | 1.64× | — |
| 过去12个月自由现金流最近4个季度 | $490.8M | — |
8季度趋势，按日历期对齐
经营现金流ALGNRDHL
| Q4 25 | $223.2M | — | ||
| Q3 25 | $188.7M | — | ||
| Q2 25 | $128.7M | — | ||
| Q1 25 | $52.7M | — | ||
| Q4 24 | $286.1M | — | ||
| Q3 24 | $263.7M | — | ||
| Q2 24 | $159.8M | — | ||
| Q1 24 | $28.7M | — |
自由现金流ALGNRDHL
| Q4 25 | $187.3M | — | ||
| Q3 25 | $169.0M | — | ||
| Q2 25 | $107.2M | — | ||
| Q1 25 | $27.4M | — | ||
| Q4 24 | $263.1M | — | ||
| Q3 24 | $233.9M | — | ||
| Q2 24 | $106.4M | — | ||
| Q1 24 | $19.3M | — |
自由现金流率ALGNRDHL
| Q4 25 | 17.9% | — | ||
| Q3 25 | 17.0% | — | ||
| Q2 25 | 10.6% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 23.9% | — | ||
| Q2 24 | 10.3% | — | ||
| Q1 24 | 1.9% | — |
资本支出强度ALGNRDHL
| Q4 25 | 3.4% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 2.6% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 5.2% | — | ||
| Q1 24 | 0.9% | — |
现金转化率ALGNRDHL
| Q4 25 | 1.64× | — | ||
| Q3 25 | 3.33× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 0.57× | — | ||
| Q4 24 | 2.76× | — | ||
| Q3 24 | 2.27× | — | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 0.27× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
